Polypharmacy burden and the associated factors among inpatients with elderly comorbidity
10.3760/cma.j.cn211501-20211103-03037
- VernacularTitle:老年共病住院患者多重用药负担及其影响因素调查
- Author:
Zhiyu WANG
1
;
Xianyu LU
;
Fengmei XING
Author Information
1. 华北理工大学护理与康复学院，唐山 063210
- Keywords:
Aged;
Comorbidity;
Influencing factors;
Polypharmacy burden;
Current status
- From:
Chinese Journal of Practical Nursing
2022;38(12):906-910
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To explore the current status and influencing factors of polypharmacy burden in inpatient with elderly comorbidity.Methods:Convenience sampling method was used to select 393 in patients with elderly comorbidity of multiple medications who were hospitalized in North China University of Science and Technology Affiliated Hospital from September 2020 to January 2021 as the research object, using the general situation questionnaire, the Living with Medicines Questionnaire (LMQ), the Perceived Social Support Scale (PSSS), the Medication Compliance Scale (Morisky Scale) to investigate. Descriptive analysis of general data characteristics and polypharmacy burden scores were performed, and t-test, variance analysis, and multiple linear stepwise regression analysis were used to analyze influencing factors. Results:The polypharmacy burden for inpatient with elderly comorbidity was (136.95 ± 22.34) points, and the score rate was 70.23%, which was at a moderately high level. Multi-factor analysis showed that age, education level, personal monthly income, the number of illnesses, the number of medications, the duration of medication, social support, and medication compliance were independent factors influencing polypharmacy burden in inpatient with elderly comorbidity ( R 2=0.821, adjusted R 2=0.818, F=220.65, P<0.001). Conclusions:The polypharmacy burden in inpatient with elderly comorbidity is at a moderately high level. It is recommended that medical staff should develop individualized nursing interventions to reduce the polypharmacy burden for the factors that affect the burden of multiple medications for this population.
